1 / 17

Multiple Myeloma

Rick Allen. Multiple Myeloma. A malignant proliferation of plasma cells derived from a single clone, with multifocal involvement of the skeleton. What is it?. 1,115 Aussies diagnosed every year Risk increases w. age : 80% are > 60 y.o . Men > women Black 2x > white

quasar
Télécharger la présentation

Multiple Myeloma

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Rick Allen Multiple Myeloma

  2. A malignant proliferation of plasma cells derived from a single clone, with multifocal involvement of the skeleton. What is it?

  3. 1,115 Aussies diagnosed every year Risk increases w. age : 80% are > 60 y.o. Men > women Black 2x > white Familial link (4x increased risk) 1% of all US cancers, 10% of haemotological cancers Epidemiology

  4. Cause is unknown, however there is evidence for genetic issues; • 11q14 and 17p13 deletions (serious) • 11q abnormalities • T(11;14)(q13;q32) , cyclin D1 (cell cycle regulatory gene) (less serious) • T(4;14)(p16;q32) heavy chain gene and tyrosine kinase receptor controls cell proliferation • Mys, ras, p53 and Rb-1 mutations Aetiology

  5. Plasma cell attaches to bone marrow stromal cell (handy because…) Monoclonal Ig (M component) is produced; potentially with excess heavy/light chains (urine) Bone destruction (↑ RANKL on OB  ↑ OC act., inhibition of OB) IL-6, IGF-1 the main players Pathophysiology

  6. Pathophysiology

  7. Are due to: • Plasma cell growth in tissue • Excessive defective Ig production • Normal humoral immunity suppression Clinical Features

  8. Bone resorption •  pathologic fractures and bone pain (usually precipitated by movement). Generalized osteoperosis • hypercalcaemia  neurologic symptoms and renal dysfunction • ↓ normal Ig production •  Recurrent bacterial infection • Cell immunity not affected • Ig breakdown increased • IgA ↑ blood viscosity  headaches, retinopathy, fatigue • Renal failure • Multifactorial cause, but primarily due to Bence-Jones proteinuria • Toxic  atrophy of tubal epithelia, pyelonephritis • Anaemia • Due to marrow involvement. Normocytic, normochromic. Pancytopenia. Clinical Features

  9. Clinical Features

  10. Destructive plasma cell tumours in axial skeleton Medullary cavity  erodes spongy bone  destroys cortical bone. Lesions 1-4cm diameter Soft, gelatinous, red tumour mass Elsewhere, ↑ marrow plasma cellularity Morphology

  11. Morphology

  12. Radiograph and lab results • 24hr urine to find Bence-Jones bodies • Electrophoresis to determine monoclonal Ig/light chains • X-rays of osteolytic lesions: require bone marrow examination to confirm. Diagnosing

  13. Some lymphomas and leukaemias (CLL) can also produce M components. Differentials

  14. Systemic treatment + symptomatic treatment Cytotoxic agents (proteasome inhibitors) Combination chemo: alters myeloma and stromal cell interaction. Inhibits angiogenesis Bisphosphonates  bone and Ca Transplant: prolongs but no cure Radiotherapy for bone pain Treatment/Management

  15. Median survival 4-6 years Multiple bony lesions  6-12 months Death usually due to either renal failure or infection Prognosis

  16. Plasmacytoma • Localised myeloma • Have the potential to spread. Easier to treat if found in soft tissue. • Monoclonal Gammopathy of Uncertain Significance (MGUS) • Same genetic abnormalities as MM • Asymptommatic w. elevated M components. • Progression to MM ~1%. Unpredictable. Should know a bit about…

  17. Robbins and Cotran, pp609-611 Harrisons, pp701-706 Underwood, pp667-669 Leukaemia association of Australia Up to Date References

More Related